AzTrials
AzTrials

StrokeNCT06231810

Tracking a Tactile Signal Along the Nervous System

A study testing Tactile stimulation in people with Stroke and Tactile Perception, run by Virginia Polytechnic Institute and State University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Quantify the flow of a tactile signal from the stimulus at the finger at the peripheral nervous system (PNS), to the central nervous system (CNS), and to cognitive perception at the brain in young adults (Aim 1) and individuals with and without stroke (Aim 2). Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Stroke, Tactile Perception
What is being tested?
Tactile stimulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteUnited States
Study dates
29 Feb 2024to 1 Jul 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • -right-hand dominance for participants who are neurotypical
  • For Aim 1:
  • -age range of 18-23
  • For Aim 2:
  • participants who are neurotypical will be a similar age to the participants with stroke
  • participants who are neurotypical will have no musculoskeletal and neurological conditions
Show all 10Show fewer
  • participants with stroke will have a single stroke incident resulting in a unilateral lesion (ischemic and hemorrhagic)
  • participants with stroke will be in the chronic phase (>1 year from stroke onset)
  • participants with stroke will have an onset of stroke after the age of 18
  • participants with stroke who meet the criteria of having the capacity to provide informed consent, regardless of aphasia

Who cannot join

  • minors
  • pregnant women
  • prisoners
  • adults not capable of consenting on their own behalf.
  • For Aim 2:
  • participants with stroke who have used antispastic injections in the past six months
Show all 9Show fewer
  • participants with stroke who have a lesion in the brainstem and/or cerebellum
  • participants with stroke who have a stroke arising due to brain surgery
  • participants with stroke who have hemineglect

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Netta Gurari, PhD contact

540-231-3073

gurari@vt.edu

United States1 site, 1 recruiting
  • Virginia Tech

    Blacksburg, Virginia, 24061

    Netta Gurari, 540-231-3073, gurari@vt.edu

    Recruiting

Other trials in United States

About this study

Quantify the flow of a tactile signal from the stimulus at the finger at the peripheral nervous system (PNS), to the central nervous system (CNS), and to cognitive perception at the brain in young adults (Aim 1) and individuals with and without stroke (Aim 2).

Being tested
Tactile stimulation
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tactile stimulationBehavioural

    Tactile stimuli of differing magnitudes will be applied

Study groups in NCT06231810
Study groupRoleWhat they receive
Stimulus magnitudeExperimentalDiffering levels of tactile stimulus will be applied
Receives: Behavioral: Tactile stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Conscious detection threshold

    The magnitude at which a force stimulus applied to the finger can be first consciously detected. Different force levels will be applied, and the participant will indicate which of these forces can be detected. The changes in force applied will be in the units of N.

    Measured: 30 minutes during the first session of a one session protocol

Secondary outcomes (1)
  1. Brain activation

    The magnitude and regions of brain activated in response to differing levels of force stimuli will be captured using fMRI. The % signal change in the brain will be used to define the brain activation in response to each force stimulus level.

    Measured: 60 minutes during the first session of a one session protocol

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2024
  2. Study start29 Feb 2024
  3. Primary completion1 Jul 2027 (estimated)
  4. Study completion1 Jul 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06231810
Sponsor's protocol ID
23-1256
Status last verified
Jun 2026
First submitted
8 Jan 2024
Last updated
17 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Tactile stimulation in people with Stroke and Tactile Perception, run by Virginia Polytechnic Institute and State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Netta Gurari, PhD (540-231-3073, gurari@vt.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Conscious detection threshold (time frame: 30 minutes during the first session of a one session protocol). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in